Stepanyants V, Li H, Cenin D, Edwards J, et al. Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil. Bone Marrow Transplant 2025 Jul 31. doi: 10.1038/s41409-025-02690.
PMID: 40745472